Patents by Inventor Michael H. O'Neal
Michael H. O'Neal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240156782Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindo1-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: December 19, 2023Publication date: May 16, 2024Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGIMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Patent number: 11890270Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: December 29, 2020Date of Patent: February 6, 2024Assignee: Siga Technologies, Inc.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A. C. L. S. Anderson, William C. Weimers, Dylan Nelson, Tove' C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20210137885Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: December 29, 2020Publication date: May 13, 2021Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGIMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Patent number: 10933050Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: July 24, 2019Date of Patent: March 2, 2021Assignee: SIGA TECHNOLOGIES INC.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A. C. L. S. Anderson, William C. Weimers, Dylan Nelson, Tove′ C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20190343799Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: July 24, 2019Publication date: November 14, 2019Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGIMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Patent number: 10406137Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: July 2, 2018Date of Patent: September 10, 2019Assignee: Siga Technologies Inc.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A.C.L.S. Anderson, William C. Weimers, Dylan Nelson, Tove′ C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20180311213Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: July 2, 2018Publication date: November 1, 2018Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Patent number: 10045964Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: July 27, 2017Date of Patent: August 14, 2018Assignee: Siga Technologies Inc.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A. C. L. S. Anderson, William C. Weimers, Dylan Nelson, Tove' C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20180193308Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: July 27, 2017Publication date: July 12, 2018Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGIMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Patent number: 9744154Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: December 4, 2015Date of Patent: August 29, 2017Assignee: SIGA TECHNOLOGIES, INC.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A.C.L.S. Anderson, William C. Weimers, Dylan Nelson, Tove′ C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Patent number: 9339466Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: GrantFiled: March 23, 2011Date of Patent: May 17, 2016Assignee: SIGA TECHNOLOGIES, INC.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A. C. L. Stone, William C. Weimers, Dylan Nelson, Tove′ C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20160107993Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: December 4, 2015Publication date: April 21, 2016Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. TYAVANAGIMATT, Melialani A.C.L.S. ANDERSON, William C. WEIMERS, Dylan NELSON, Tove' C. BOLKEN, Dennis E. HRUBY, Michael H. O'NEILL, Gary SWEETAPPLE, Kelley A. McCLOUGHAN
-
Publication number: 20130136693Abstract: The present invention provides novel crystalline polymorphic forms of 2-cyclohexylmethylidenehydrazino adenosine, also known as binodenoson, methods of making the same, and methods for the manufacture of a pharmaceutical composition by employing such crystal forms, in particular, for the use of binodenoson in a subject, in need thereof, as a pharmacological stress agent to produce coronary vasodilation.Type: ApplicationFiled: July 11, 2012Publication date: May 30, 2013Applicant: King Pharmaceuticals Research and Development, IncInventors: Allan R. Moorman, Michael H. O'Neal
-
Publication number: 20110236434Abstract: Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.Type: ApplicationFiled: March 23, 2011Publication date: September 29, 2011Applicant: Siga Technologies, Inc.Inventors: Shanthakumar R. Tyavanagimatt, Melialani A.C.L. Stone, William C. Weimers, Dylan Nelson, Tove' C. Bolken, Dennis E. Hruby, Michael H. O'Neill, Gary Sweetapple, Kelley A. McCloughan
-
Publication number: 20110044904Abstract: The present invention provides novel crystalline polymorphic forms of 2-cyclohexylmethylidenehydrazino adenosine, also known as binodenoson, methods of making the same, and methods for the manufacture of a pharmaceutical composition by employing such crystal forms, in particular, for the use of binodenoson in a subject, in need thereof, as a pharmacological stress agent to produce coronary vasodilation.Type: ApplicationFiled: February 27, 2009Publication date: February 24, 2011Inventors: Allan R. Moorman, Michael H. O'Neill
-
Patent number: 5962630Abstract: A method of encapsulating mixed waste in which a thermoplastic polymer having a melting temperature less than about 150.degree. C. and sulfur and mixed waste are mixed at an elevated temperature not greater than about 200.degree. C. and mixed for a time sufficient to intimately mix the constituents, and then cooled to a solid. The resulting solid is also disclosed.Type: GrantFiled: December 3, 1997Date of Patent: October 5, 1999Assignee: The United States of America as represented by the United States Department of EnergyInventors: Michael H. O'Brien, Arnold W. Erickson
-
Patent number: 5316988Abstract: A method of fabricating a SiAlON ceramic body includes: a) combining quantities of Si.sub.3 N.sub.4, Al.sub.2 O.sub.3 and CeO.sub.2 to produce a mixture; b) forming the mixture into a desired body shape; c) heating the body to a densification temperature of from about 1550.degree. C. to about 1850.degree. C.; c) maintaining the body at the densification temperature for a period of time effective to densify the body; d) cooling the densified body to a devitrification temperature of from about 1200.degree. C. to about 1400.degree. C.; and e) maintaining the densified body at the devitrification temperature for a period of time effective to produce a .beta.'-SiAlON crystalline phase in the body having elemental or compound form Ce incorporated in the .beta.'-SiAlON crystalline phase. Further, a SiAlON ceramic body comprises: a) an amorphous phase; and b) a crystalline phase, the crystalline phase comprising .beta.'-SiAlON having lattice substituted elemental or compound form Ce.Type: GrantFiled: August 2, 1993Date of Patent: May 31, 1994Assignee: EG&G Idaho, Inc.Inventors: Michael H. O'Brien, Blair H. Park
-
Patent number: 5006142Abstract: The invention is a process for the preparation of high quality oxynitride glasses without resorting to high pressures. Nitrogen-containing compounds such as Si.sub.3 N.sub.4 are first encapsulated in a low melting temperature glass. Particles of the encapsulated nitrogen-containing compound are mixed with other oxide glass-formers and melted in an atmosphere of flowing nitrogen and in the presence of buffering gas to form the oxynitride glass. Glasses containing up to 15 at % nitrogen have been prepared by this method.Type: GrantFiled: March 28, 1990Date of Patent: April 9, 1991Assignee: The United States of America as represented by the United States Department of EnergyInventors: Jerry R. Weidner, Stanley T. Schuetz, Michael H. O'Brien
-
Patent number: 4996707Abstract: A computer system is described that includes a capability to receive and store graphic images from remote facsimile machines. The system includes a software that can convert graphic images of textual material into an ASCII coded file so that either keywords or the coverted text may be converted to speech giving the addressee-user the ability to review incoming facsimiles from a remote telephone. The system includes a relay capability, the capability to print on command and to originate facsimiles either from text files or scanned papers.Type: GrantFiled: February 9, 1989Date of Patent: February 26, 1991Assignee: Berkeley Speech Technologies, Inc.Inventors: Sara O'Malley, Michael H. O'Malley, Elisabeth Peters
-
Patent number: 4392258Abstract: An article of clothing in the nature of a T-shirt having a semi-stiff bill at the rear of the neck opening. The clothing can be worn as an ordinary shirt with the bill depending from the back of the neck opening or it can be worn over the head with the bill in front serving as an eyeshade.Type: GrantFiled: December 16, 1982Date of Patent: July 12, 1983Inventor: Michael H. O'Neill